Page last updated: 2024-08-23

daunorubicin and 4-hydroxy-2-nonenal

daunorubicin has been researched along with 4-hydroxy-2-nonenal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Kabbani, O; Endo, S; Hara, A; Ikari, A; Kezuka, C; Matsunaga, T; Morikawa, Y; Tajima, K; Takazawa, H; Yamaguchi, A	1

Other Studies

1 other study(ies) available for daunorubicin and 4-hydroxy-2-nonenal

Article	Year
Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells. Anti-cancer drugs, 2014, Volume: 25, Issue:8 Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Aldehydes; Aldo-Keto Reductase Family 1 Member C3; Antibiotics, Antineoplastic; Apoptosis; Cell Differentiation; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; Lipid Peroxidation; Reactive Oxygen Species; U937 Cells	2014

Article

Year

Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells.

Anti-cancer drugs, 2014, Volume: 25, Issue:8

Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Aldehydes; Aldo-Keto Reductase Family 1 Member C3; Antibiotics, Antineoplastic; Apoptosis; Cell Differentiation; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; Lipid Peroxidation; Reactive Oxygen Species; U937 Cells

2014